Papers associated with mal

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	RFX6 regulates human intestinal patterning and function upstream of PDX1., Sanchez JG, Rankin S, Paul E, McCauley HA, Kechele DO, Enriquez JR, Jones NH, Greeley SAW, Letourneau-Friedberg L, Zorn AM, Krishnamurthy M, Wells JM., Development. April 8, 2024;
	ALISA: A microplate assay to measure protein thiol redox state., Noble A, Guille M, Cobley JN., Free Radic Biol Med. October 1, 2021; 174 272-280.
	The evolutionary conserved FOXJ1 target gene Fam183b is essential for motile cilia in Xenopus but dispensable for ciliary function in mice., Beckers A, Ott T, Schuster-Gossler K, Boldt K, Alten L, Ueffing M, Blum M, Gossler A., Sci Rep. October 2, 2018; 8 (1): 14678.
	A single XLF dimer bridges DNA ends during nonhomologous end joining., Graham TGW, Carney SM, Walter JC, Loparo JJ., Nat Struct Mol Biol. September 1, 2018; 25 (9): 877-884.
	Xenopus GLP-1-inspired discovery of novel GLP-1 receptor agonists as long-acting hypoglycemic and insulinotropic agents with significant therapeutic potential., Han J, Chen X, Wang Y, Fei Y, Zhou F, Zhang Y, Liu L, Si P, Fu J., Biochem Pharmacol. October 15, 2017; 142 155-167.
	Functional variants in HCN4 and CACNA1H may contribute to genetic generalized epilepsy., Becker F, Reid CA, Hallmann K, Tae HS, Phillips AM, Teodorescu G, Weber YG, Kleefuss-Lie A, Elger C, Perez-Reyes E, Petrou S, Kunz WS, Lerche H, Maljevic S., Epilepsia Open. August 5, 2017; 2 (3): 334-342.
	Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents., Han J, Wang Y, Meng Q, Li G, Huang F, Wu S, Fei Y, Zhou F, Fu J., Eur J Med Chem. May 26, 2017; 132 81-89.
	A mannitol/sorbitol receptor stimulates dietary intake in Tribolium castaneum., Takada T, Sato R, Kikuta S., PLoS One. January 1, 2017; 12 (10): e0186420.
	Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of α7 Nicotinic Acetylcholine Receptor., Lyukmanova EN, Shulepko MA, Kudryavtsev D, Bychkov ML, Kulbatskii DS, Kasheverov IE, Astapova MV, Feofanov AV, Thomsen MS, Mikkelsen JD, Shenkarev ZO, Tsetlin VI, Dolgikh DA, Kirpichnikov MP., PLoS One. January 1, 2016; 11 (2): e0149733.
	Pou-V factor Oct25 regulates early morphogenesis in Xenopus laevis., Julier A, Goll C, Korte B, Knöchel W, Wacker SA., Dev Growth Differ. September 1, 2012; 54 (7): 702-16.
	Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form., Geissler S, Hellwig M, Markwardt F, Henle T, Brandsch M., Eur J Pharm Biopharm. May 1, 2011; 78 (1): 75-82.
	Role of GluR1 in activity-dependent motor system development., Zhang L, Schessl J, Werner M, Bonnemann C, Xiong G, Mojsilovic-Petrovic J, Zhou W, Cohen A, Seeburg P, Misawa H, Jayaram A, Personius K, Hollmann M, Sprengel R, Kalb R., J Neurosci. October 1, 2008; 28 (40): 9953-68.
	Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda., Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, Huber M, Bertrand D, Hohl D., Hum Mol Genet. November 15, 2003; 12 (22): 3017-24.
	Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction., Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA., Nature. September 6, 2001; 413 (6851): 78-83.
	Xebf3 is a regulator of neuronal differentiation during primary neurogenesis in Xenopus., Pozzoli O, Bosetti A, Croci L, Consalez GG, Vetter ML., Dev Biol. May 15, 2001; 233 (2): 495-512.
	A novel POZ/zinc finger protein, champignon, interferes with gastrulation movements in Xenopus., Goto T, Hasegawa K, Kinoshita T, Kubota HY., Dev Dyn. May 1, 2001; 221 (1): 14-25.
	Cellular heterogeneity of ammonium ion transport across the basolateral membrane of the hamster medullary thick ascending limb of Henle's loop., Tsuruoka S, Takeda M, Yoshitomi K, Imai M., J Clin Invest. October 1, 1993; 92 (4): 1881-8.

???pagination.result.page??? 1